Prevalencia de Cryptosporidium en muestras de materia fecal llevadas a diez laboratorios del Area Metropolitana de Bucaramanga, Colombia

Zaraza, Carmen; Díaz, Luis; Vargas, Liliana; Santos, Ricardo; Sepúlveda, Janner; Pinto, Martha; Tarazona, Carlos; Rojas, Freddy; Torres, Diego; Ortega, Marjorie.
Med. UIS ; 8(1): 2-5, ene.-mar. 1994. tab
Artículo en Español | LILACS | ID: lil-232149

Documentos relacionados

  1. Cryptosporidiosis: environmental, therapeutic, and preventive challenges.
  2. Cryptosporidiosis.
  3. Investigation of the prophylactic and therapeutic effectiveness of oral thyme extract in rats experimentally infected with cryptosporidium parvum.
  4. Curcumin mitigates Cryptosporidium parvum infection through modulation of gut microbiota and innate immune-related genes in immunosuppressed neonatal mice.
  5. Cryptosporidium species: new insights and old challenges.
  6. Challenges in understanding the immunopathogenesis of Cryptosporidium infections in humans.
  7. Bovine cryptosporidiosis: impact, host-parasite interaction and control strategies.
  8. [Intestinal pathological changes of Kunming mice infected by Cryptosporidium and the therapeutic efficacy of spiramycin on infected mice].
  9. Development of Two Mouse Models for Vaccine Evaluation against Cryptosporidiosis.
  10. Advances in therapeutic and vaccine targets for Cryptosporidium: Challenges and possible mitigation strategies.